(Q73523474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Basement membrane peptides as markers of liver disease in chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

1 reference

1 reference

K M Walsh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Fletcher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R N MacSween

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A J Morris

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

325-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Sensitive radioimmunoassays for 7 S collagen and laminin: Application to serum and tissue studies of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

The biosynthesis of collagen and its disorders (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

A computer program for non-parametric receiver operating characteristic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver d

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-termina

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum type IV collagen and prolyl hydroxylase levels: effect of gender and age

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum laminin P1 in chronic viral hepatitis: correlations with liver histological activity and diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

One-step sandwich enzyme immunoassay for human laminin using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

Serum concentrations of laminin in cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980079-3

7 January 2021

10.1016/S0168-8278(00)80079-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707874%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference